Inventor · disambiguated record
Ole Isacson
Also filed as: ISACSON OLE
12 granted patents·13 pending applications·95 citations·filing 1995–2019
89Inventor score
Files withISACSON OLE7MCLEAN HOSPITAL CORP6UNIV ROSALIND FRANKLIN MEDICINE & SCIENCE3DIACRIN INC2BIOGEN IDEC MA INC AND MCLEAN1
Top patents by PatentIndex Score
25 records- 0190US9968637B2Dopaminergic neurons differentiated from pluripotent stem cells and uses thereofMCLEAN HOSPITAL CORP·Filed 2015·Granted May 15, 2018·13 cites·8 claims
- 0288US9840710B2Antisense compounds targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of parkinsons diseaseUNIV ROSALIND FRANKLIN MEDICINE & SCIENCE·Filed 2016·Granted Dec 12, 2017·6 cites·14 claims
- 0385US9249389B2Methods for isolating early neurons and neuroblastsMCLEAN HOSPITAL CORP·Filed 2013·Granted Feb 2, 2016·9 cites·14 claims
- 0485US8153422B2Dopaminergic neurons differentiated from embryonic cells for treating neurodegenerative diseasesISACSON OLE·Filed 2008·Granted Apr 10, 2012·9 cites·12 claims
- 0577US6258353B1Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseasesDIACRIN INC·Filed 1995·Granted Jul 10, 2001·32 cites·26 claims
- 0669US6294383B1Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseasesMCLEAN HOSPITAL CORP·Filed 1995·Granted Sep 25, 2001·25 cites·8 claims
- 0768US10967073B2Glucocerebrosidase gene therapy for Parkinson's diseaseSHIRE HUMAN GENETIC THERAPIES·Filed 2016·Granted Apr 6, 2021·1 cites·14 claims
- 0867US2011135696A1Multipotent neural cellsMCLEAN HOSPITAL CORP·Filed 2009·Application pending·0 cites
- 0966US10787669B2Antisense compounds targeting Leucine-Rich repeat kinase 2(LRRK2) for the treatment of Parkinsons diseaseUNIV ROSALIND FRANKLIN MEDICINE & SCIENCE·Filed 2019·Granted Sep 29, 2020·0 cites·27 claims
- 1059US10370667B2Antisense compounds targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of parkinsons diseaseUNIV ROSALIND FRANKLIN MEDICINE & SCIENCE·Filed 2017·Granted Aug 6, 2019·0 cites·16 claims
- 1155US8545834B2G-substrate for the treatment and prevention of parkinson's diseaseISACSON OLE·Filed 2008·Granted Oct 1, 2013·0 cites·6 claims
- 1255US2010021437A1Neural stem cells derived from induced pluripotent stem cellsMCLEAN HOSPITAL CORP WHITEHEAD·Filed 2009·Application pending·0 cites
- 1355US2006078890A1Methods for identifying parkinson's disease therapeuticsISACSON OLE·Filed 2004·Application pending·0 cites
- 1454US2014065227A1Neural stem cells derived from induced pluripotent stem cellsWHITEHEAD BIOMEDICAL INST·Filed 2013·Application pending·0 cites
- 1554US2004214324A1Dopaminergic neurons differentiated from embryonic cells for treating neurodegenerative diseasesFiled 2003·Application pending·0 cites
- 1653US2002009461A1Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseasesDIACRIN INC·Filed 2001·Application pending·0 cites
- 1752US8586558B2RAB3B for treatment and prevention of Parkinson's diseaseISACSON OLE·Filed 2009·Granted Nov 19, 2013·0 cites·6 claims
- 1847US2016095887A1Multipotent neural cellsISACSON OLE·Filed 2015·Application pending·0 cites
- 1945US7585962B2Multimerized enhancer domains for cell-specific expressionMCLEAN HOSPITAL CORP·Filed 2002·Granted Sep 8, 2009·0 cites·5 claims
- 2044US2009246189A1Methods for Promoting Neurite Outgrowth and Survival of Dopaminergic NeuronsBIOGEN IDEC MA INC AND MCLEAN·Filed 2006·Application pending·0 cites
- 2144US2002114788A1Cell implantation therapy for neurological diseases or disordersFiled 2001·Application pending·0 cites
- 2244US2013261165A1Prevention and treatment of diseases characterized by mesencephalic dopaminergic neuron cell deathISACSON OLE·Filed 2011·Application pending·0 cites
- 2343US2013108669A1Dopaminergic neurons differentiated from pluripotent stem cells and uses of thereofCOOPER OLIVER·Filed 2011·Application pending·0 cites
- 2440US2018243343A1Methods and compositions for the treatment or prevention of parkinson's diseaseMCLEAN HOSPITAL CORP·Filed 2016·Application pending·0 cites
- 2528US2013274235A1Treatment of motor neuron diseaseISACSON OLE·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ole Isacson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →